Cinnarizine: Indications, Dosage, and Contraindications
I cannot provide specific information about cinnarizine from the evidence provided, as the studies reference meclizine hydrochloride, not cinnarizine - these are different medications despite both being antihistamines used for vestibular disorders 1.
However, based on the research evidence available on cinnarizine specifically:
Indications
Cinnarizine is indicated for vestibular vertigo (both peripheral and central origin), motion sickness, nausea, vomiting, and inner ear disorders 2. The drug works through anti-vasoconstrictor activity, reducing blood viscosity and nystagmus in the labyrinth 2.
Specific Clinical Uses:
- Vestibular vertigo: Acts predominantly peripherally on the labyrinth 2
- Motion sickness prevention: Effective in car sickness and seasickness 3, 4, 5
- Acquired cold urticaria: High-dose cinnarizine (25 mg three times daily) showed 57.1% complete response and 14.3% good response 6
Dosage
Motion Sickness:
- Children: 15 mg tablet 2 hours before travel, then half-tablet (7.5 mg) every 8 hours as needed 3
- Adults (seasickness): 50 mg is significantly more effective than 25 mg - 65% improvement versus 41% with lower dose 4, 5
Vertigo Treatment:
- Standard dose: 20 mg three times daily (often combined with dimenhydrinate 40 mg) 7, 8
- High-dose for cold urticaria: 25 mg three times daily for 3 months, then tapered over 2 months 6
- Treatment duration: Typically 60 days for vertigo symptoms 8
The fixed combination of cinnarizine 20 mg plus dimenhydrinate 40 mg three times daily demonstrated superior efficacy compared to betahistine or either component alone 7, 9.
Contraindications
The provided evidence does not contain specific FDA-approved contraindications for cinnarizine. However, important safety considerations include:
Cautions and Restrictions:
- Aircrew: Contraindicated for pilots and aircrew involved in aircraft control due to central nervous system effects including drowsiness and impaired performance 10
- Performance impairment: Even 15 mg reduces sleep latencies at 3.5-5 hours post-dose; 30-45 mg causes measurable performance impairment 5-8 hours after ingestion 10
- Elderly patients: Use with caution due to potential for increased side effects
- Hepatic/renal impairment: Monitor closely (extrapolated from general antihistamine precautions)
Common Adverse Effects:
- Drowsiness (14% in children) 3
- Epigastric pain, weight gain, mild drowsiness 6
- Severe vertigo (rare - led to discontinuation in one patient) 6
- Generally well-tolerated: 97.9% of patients rated tolerability as "good" or "very good" 7
Clinical Pearls
- Onset of action: Cinnarizine should be taken 2 hours before anticipated motion exposure 3
- Gender differences: Some evidence suggests differential efficacy between males and females, though both benefit 8
- Combination therapy: The fixed combination with dimenhydrinate provides complementary mechanisms - cinnarizine acts peripherally on the labyrinth while dimenhydrinate acts centrally on vestibular nuclei 2
- Vomiting protection: 50 mg dose provides 63% protection against vomiting in rough seas 5